SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of DaVita Inc. (DVA)

NEW YORK, Jan. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors can obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/dva.

The investigation concerns whether DaVita and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On January 6, 2017, after market hours, the Wall Street Journal issued a report revealing that DaVita had received subpoenas from federal prosecutors asking for "the production of information related to charitable premium assistance" in regards to the Company's ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis. Following this news, DaVita stock dropped about 4% during intraday trading on January 9, 2017.

If you are aware of any facts relating to this investigation, or purchased DaVita shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/dva.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.  Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links

http://www.bgandg.com